SABCS (@sabcssanantonio) 's Twitter Profile
SABCS

@sabcssanantonio

An international scientific symposium for interaction and exchange among basic scientists and clinicians in breast cancer

ID: 2778609876

linkhttp://www.sabcs.org calendar_today29-08-2014 15:19:05

5,5K Tweet

13,13K Followers

715 Following

SABCS (@sabcssanantonio) 's Twitter Profile Photo

#SABCS24 Recap: Steffi Oesterreich, PhD, the 2024 recipient of the AACR Distinguished Lectureship in Breast Cancer Research, shared her work on invasive lobular carcinoma. Learn more in Visit SABCS Meeting News: bit.ly/3PsLy2A

#SABCS24 Recap: Steffi Oesterreich, PhD, the 2024 recipient of the AACR Distinguished Lectureship in Breast Cancer Research, shared her work on invasive lobular carcinoma. Learn more in Visit SABCS Meeting News: 
bit.ly/3PsLy2A
SABCS (@sabcssanantonio) 's Twitter Profile Photo

A special session at #SABCS24 highlighted the science behind recent FDA approvals of breast cancer drugs. Read a recap in SABCS Meeting News: bit.ly/4fRvv9y

A special session at #SABCS24 highlighted the science behind recent FDA approvals of breast cancer drugs. Read a recap in SABCS Meeting News:
bit.ly/4fRvv9y
SABCS (@sabcssanantonio) 's Twitter Profile Photo

Neil M. Iyengar, MD, joined a panel discussion at #SABCS24 on reducing obesity-related risk of breast cancer. Learn more in SABCS Meeting News: bit.ly/40droyJ

Neil M. Iyengar, MD, joined a panel discussion at #SABCS24 on reducing obesity-related risk of breast cancer. Learn more in SABCS Meeting News: 
bit.ly/40droyJ
SABCS (@sabcssanantonio) 's Twitter Profile Photo

Read #SABCS24 Takeaways magazine for the latest updates in breast cancer research. Available now in SABCS Meeting News: bit.ly/3PVfBAe

SABCS (@sabcssanantonio) 's Twitter Profile Photo

#SABCSSnippets: Hope Rugo and Kate Lathrop discuss the recent FDA approval of Dato-DXd for unresectable or metastatic, HR-positive, HER2-negative breast cancer. Efficacy was evaluated in the TROPION-Breast01, which was previously presented at #SABCS23. brnw.ch/21wQw8g

#SABCSSnippets: Hope Rugo and Kate Lathrop discuss the recent FDA approval of Dato-DXd for unresectable or metastatic, HR-positive, HER2-negative breast cancer. Efficacy was evaluated in the TROPION-Breast01, which was previously presented at #SABCS23.
brnw.ch/21wQw8g
Medical Digest & Congress Report (@medicaldigestcr) 's Twitter Profile Photo

🎥 Kate Lathrop, MD discuss some of the high impact, clinically relevant, clinical trials that were presented at SABCS24. -> medicaldigest.org/scientific-con… Long School of Medicine SABCS #BreastCancer

SABCS (@sabcssanantonio) 's Twitter Profile Photo

Codirectors Carlos L. Arteaga and Virginia G. Kaklamani and the rest of the #SABCS25 program committee met in Atlanta to develop the program for #SABCS25. We look forward to seeing everyone in San Antonio December 9-12. Carlos L. Arteaga, M.D. VIRGINIA KAKLAMANI @UTHealthSAMDA AACR Margaret Foti, PhD, MD (hc)

Codirectors Carlos L. Arteaga and Virginia G. Kaklamani and the rest of the #SABCS25 program committee met in Atlanta to develop the program for #SABCS25. We look forward to seeing everyone in San Antonio December 9-12.
<a href="/CarlosArteagaMD/">Carlos L. Arteaga, M.D.</a> <a href="/VKaklamani/">VIRGINIA KAKLAMANI</a> @UTHealthSAMDA <a href="/AACR/">AACR</a> <a href="/AACR_CEO/">Margaret Foti, PhD, MD (hc)</a>
SABCS (@sabcssanantonio) 's Twitter Profile Photo

We are in Tampa this week at the Society of Surgical Oncology Annual Meeting (March 27-29). Visit us in Booth 107 today through Saturday to learn more about the most important breast cancer meeting in the world, and make plans to join us in San Antonio December 9-12 for #SABCS25. #SSO2025

We are in Tampa this week at the <a href="/SocSurgOnc/">Society of Surgical Oncology</a> Annual Meeting (March 27-29). Visit us in Booth 107 today through Saturday to learn more about the most important breast cancer meeting in the world, and make plans to join us in San Antonio December 9-12 for #SABCS25. 
#SSO2025
AACR (@aacr) 's Twitter Profile Photo

Updates from SABCS 2024: On Tuesday, April 29, Charles M. Perou and San Antonio Breast Cancer Symposium codirector Carlos L. Arteaga, M.D. will cochair this special #AACR25 session highlighting four clinical trials presented at #SABCS24. brnw.ch/21wRH0K SABCS

Updates from SABCS 2024: 
On Tuesday, April 29, Charles M. Perou and San Antonio Breast Cancer Symposium codirector <a href="/CarlosArteagaMD/">Carlos L. Arteaga, M.D.</a> will cochair this special #AACR25 session highlighting four clinical trials presented at #SABCS24. 
brnw.ch/21wRH0K <a href="/SABCSSanAntonio/">SABCS</a>
SABCS (@sabcssanantonio) 's Twitter Profile Photo

New #SABCSSnippets: Virginia Kaklamani and Sara Tolaney discuss results from two potentially practice-changing trials that were released this week—the Phase 3 DESTINY-Breast09 trial and the Phase III ASCENT-04/KEYNOTE-D19 study. brnw.ch/21wScb8

New #SABCSSnippets: Virginia Kaklamani and Sara Tolaney discuss results from two potentially practice-changing trials that were released this week—the Phase 3 DESTINY-Breast09 trial and the Phase III ASCENT-04/KEYNOTE-D19 study.
brnw.ch/21wScb8
AACR (@aacr) 's Twitter Profile Photo

#AACRFellows Carlos Arteaga and Charles M. Perou moderated a special session on "Updates from SABCS 2024" at #AACR25. #SABCS25 will take place December 9-12, 2025. Carlos L. Arteaga, M.D.

#AACRFellows Carlos Arteaga and Charles M. Perou moderated a special session on "Updates from SABCS 2024" at #AACR25. #SABCS25 will take place December 9-12, 2025. 
<a href="/CarlosArteagaMD/">Carlos L. Arteaga, M.D.</a>
SABCS (@sabcssanantonio) 's Twitter Profile Photo

Abstract submission is now open for the San Antonio Breast Cancer Symposium, December 9-12, 2025. Abstract deadline: July 9. Learn more: brnw.ch/21wSlHf #SABCS25

Abstract submission is now open for the San Antonio Breast Cancer Symposium, December 9-12, 2025. 
Abstract deadline: July 9. Learn more:
brnw.ch/21wSlHf
#SABCS25
SABCS (@sabcssanantonio) 's Twitter Profile Photo

Abstract submission is now open for the San Antonio Breast Cancer Symposium, December 9-12, 2025. Abstract deadline: July 9. Learn more: brnw.ch/21wStZG #SABCS25

Abstract submission is now open for the San Antonio Breast Cancer Symposium, December 9-12, 2025. 
Abstract deadline: July 9. Learn more:
brnw.ch/21wStZG
#SABCS25
SABCS (@sabcssanantonio) 's Twitter Profile Photo

New #SABCSSnippets: Saba Shaikh and Shanu Modi discuss results of the Phase III DESTINY-Breast11 trial, which show the promise of Enhertu as an alternative to anthracycline-based regimens for high-risk, locally advanced HER2+ breast cancer patients: brnw.ch/21wSArc

New #SABCSSnippets: Saba Shaikh and Shanu Modi discuss results of the Phase III DESTINY-Breast11 trial, which show the promise of Enhertu as an alternative to anthracycline-based regimens for high-risk, locally advanced HER2+ breast cancer patients:
brnw.ch/21wSArc
SABCS (@sabcssanantonio) 's Twitter Profile Photo

Breast cancer clinicians and scientists from around the world will come together at #SABCS25 (December 9-12). Submit an abstract by July 9 and join them. Learn more: brnw.ch/21wSLHw

Breast cancer clinicians and scientists from around the world will come together at #SABCS25 (December 9-12). Submit an abstract by July 9 and join them. Learn more: 
brnw.ch/21wSLHw
SABCS (@sabcssanantonio) 's Twitter Profile Photo

Housing is now open for #SABCS25 (December 9-12). Make your reservations now to secure the best available hotels. Deadline: November 17. Learn more: brnw.ch/21wSR6p

Housing is now open for #SABCS25 (December 9-12). Make your reservations now to secure the best available hotels. 
Deadline: November 17. Learn more:
brnw.ch/21wSR6p
SABCS (@sabcssanantonio) 's Twitter Profile Photo

Five highly-rated abstracts on lobular carcinoma submitted for presentation at #SABCS25 will receive merit awards sponsored by the Lobular Breast Cancer Alliance in collaboration with the AACR. Submit your abstracts by July 9. Learn more: brnw.ch/21wSXB5 Lobular Breast Cancer Alliance

Five highly-rated abstracts on lobular carcinoma submitted for presentation at #SABCS25 will receive merit awards sponsored by the Lobular Breast Cancer Alliance in collaboration with the <a href="/AACR/">AACR</a>. Submit your abstracts by July 9. Learn more:
brnw.ch/21wSXB5
<a href="/LobularBCA/">Lobular Breast Cancer Alliance</a>
SABCS (@sabcssanantonio) 's Twitter Profile Photo

Joyce O’Shaughnessy moderated a panel discussion highlighting key takeaways from #SABCS24, featuring Cristina Saura, Antonio Wolff, Atif Khan, Stacey Tinianov, and Alastair Thompson. Watch now: brnw.ch/21wT38o Antonio Wolff, MD (#HealthPolicyIsEconomicPolicy) Atif J Khan Alastair Thompson

Joyce O’Shaughnessy moderated a panel discussion highlighting key takeaways from #SABCS24, featuring Cristina Saura, Antonio Wolff, Atif Khan, Stacey Tinianov, and Alastair Thompson. Watch now:
brnw.ch/21wT38o
<a href="/awolff/">Antonio Wolff, MD (#HealthPolicyIsEconomicPolicy)</a> <a href="/theRADSofKHAN/">Atif J Khan</a> <a href="/ProfAMThompson/">Alastair Thompson</a>
SABCS (@sabcssanantonio) 's Twitter Profile Photo

Submit an abstract by July 9 and share your work with the breast cancer research community at #SABCS25 (December 9-12). Learn more: brnw.ch/21wT840

Submit an abstract by July 9 and share your work with the breast cancer research community at #SABCS25 (December 9-12). Learn more: 
brnw.ch/21wT840